// App-Quantinova.ai

OP0006 (2021) : ASSOCIATIONS OF BASELINE USE OF BIOLOGIC OR TARGETED SYNTHETIC DMARDS WITH COVID-19 SEVERITY IN RHEUMATOID ARTHRITIS: RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE

Researchers

Presenter

  • J. Sparks

Principal Investigators

  • A. Seet

  • M. Gianfrancesco

  • Z. Izadi

  • K. Hyrich

  • A. Strangfeld

  • L. Gossec

  • L. Carmona

  • E. Mateus

  • S. Lawson-Tovey

  • L. Trupin

  • G. Schmajuk

  • P. Katz

  • L. Jacobsohn

  • S. Al Emadi

  • E. Gilbert

  • A. Duarte-Garcia

  • M. Valenzuela-Almada

  • T. Hsu

  • K. Dsilva

  • P. Dieud

  • E. Nikiphorou

  • V. Kronzer

  • N. Singh

  • M. F. Ugarte-Gil

  • A. Akpabio

  • R. Thomas

  • S. Bhana

  • W. Costello

  • R. Grainger

  • J. Hausmann

  • J. Liew

  • E. Sirotich

  • P. Sufka

  • P. Robinson

  • P. Machado

  • J. Yazdany

Medical Centers

  • Brigham and Women’s Hospital, Harvard Medical School, Division of Rheumatology, Immunology and Allergy, Boston, United States of America

  • Harvard Medical School, Division of Rheumatology and Clinical Immunology, Boston, United States of America

  • Massachusetts General Hospital, Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Boston, United States of America

  • University of California, San Francisco, Department of Epidemiology and Biostatistics, San Francisco, United States of America

  • The University of Manchester, Centre for Epidemiology Versus Arthritis, M13 9PT, United Kingdom

  • The University of Manchester, National Institute for Health Research Manchester Biomedical Research Centre, Manchester, United Kingdom

  • Institute Pierre Louis Epidemiology And Public Health, INSERM, Paris, France

  • University Hospitals Pitié Salpêtrière - Charles Foix, Rheumatology Department, Paris, France

  • Instituto de Salud Musculoesquelética, Rheumatology, Madrid, Spain

  • Portuguese League Against Rheumatic Diseases, Rheumatology Department, Lisbon, Portugal

  • European League Against Rheumatism (EULAR) Standing Committee, People with Arthritis/Rheumatism in Europe (PARE), Kilchberg, Switzerland

  • San Francisco VA Medical Center, Division of Rheumatology, San Francisco, United States of America

  • Hamad Medical Corporation, Medicine/Rheumatology, Doha, Qatar

  • Mayo Clinic, Rheumatology, Rochester, MN, United States of America

  • Mayo Clinic, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, United States of America

  • Bichat-Claude Bernard Hospital, Pneumologie, Paris, France

  • King’s College London, Centre for Rheumatic Disease, London, United Kingdom

  • University of Washington, Division of Medical Genetics, Seattle, United States of America

  • Scientific University of the South, Rheumatology Department, Lima, Peru

  • University of Michigan Health System, Department of Internal Medicine, Ann Arbor, United States of America

  • VA Ann Arbor Healthcare System, Center for Clinical Management Research, Ann Arbor, United States of America

  • Royal Hallamshire Hospital, Rheumatology Department, Sheffield, United Kingdom

  • University of Queensland Diamantina Institute, Brisbane, Australia

  • Crystal Run Health, Rheumatology Department, Middletown, United States of America

  • Irish Children’s Arthritis Network, Arthritis Department, Tipperary, Ireland

  • University of Otago, Rheumatology Department, Dunedin, New Zealand

  • Boston Children’s Hospital, Immunology, Boston, United States of America

  • Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, Division of Rheumatology and Clinical Immunology, Boston, United States of America

  • Boston University, Rheumatology, Boston, United States of America

  • McMaster University, Department of Health Research Methods, Evidence and Impact, Department of Medicine, Hamilton, Canada

  • Canadian Arthritis Patient Alliance, Arthritis Department, Toronto, Canada

  • Healthpartners, Rheumatology Department, St Paul, United States of America

  • University of Queensland School of Medicine, Brisbane, Queensland, Australia

  • Metro North Hospital and Health Service, Faculty of Medicine, Queensland, Australia

  • University College London, Centre for Rheumatology Research & MRC Centre for Neuromuscular Diseases, London, United Kingdom

  • University College London Hospitals National Health Service (NHS) Trust, National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre, London, United Kingdom

  • Northwick Park Hospital, Department of Endocrinology, London, United Kingdom

Locations

  • United States

  • United Kingdom

  • Germany

  • France

  • Spain

  • Portugal

  • Switzerland

  • Qatar

  • Peru

  • Australia

  • Ireland

  • New Zealand

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

  • Oncology (ONC)

  • Infectious Diseases (ID)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Interstitial lung disease

  • Rheumatoid arthritis

  • Inflammatory Arthritis

  • Coronavirus disease

  • Obesity

  • Solid malignancies

Biomarkers

  • Janus kinase

Drug/Treatment

  • Glucocorticoid

  • ILS-969

  • Interleukin

  • Abatacept

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Amgen and Bristol-Myers Squibb

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved